Clinical Trial Update: A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Mabthera (rituximab) with FCR versus Mabthera with chlorambil in chronic lymphocytic leukemia with unfavorable somatic status; study ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Chlorambucil (chlorambucil)
• Fludarabine (Fludarabine)
• MabThera (Rituximab) (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Phase 4 | Status: TERMINATED | Results posted: 2019-03-14